Last reviewed · How we verify
NCT04719533
Outcomes Following Pre-marking of Episiotomy Location
NA trial testing Pre-marking of episiotomy location in Episiotomy; Complications in 500 participants. Status unknown.
24 September 2025
Quick facts
| Lead sponsor | Sharon Davidesko MD |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 500 |
| Start date | 17 May 2021 |
| Primary completion | 24 September 2025 |
| Estimated completion | 24 September 2025 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Pre-marking of episiotomy location
Conditions studied
- Episiotomy; Complications — all drugs for Episiotomy; Complications →
- Episiotomy Extended by Laceration — all drugs for Episiotomy Extended by Laceration →
- Episiotomy Infection — all drugs for Episiotomy Infection →
Sponsor
Sharon Davidesko MD
Who can join
18 and older, female only, with Episiotomy; Complications or Episiotomy Extended by Laceration. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare short- and long-term outcomes of women following episiotomy during the second stage of labor, following marking of episiotomy location during the first stage of labor with those of women who underwent episiotomy without marking.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04719533
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04719533 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sharon Davidesko MD
- Last refreshed: 21 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04719533.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing